Condition: Emerging Infectious Diseases · Communicable Diseases · Biological Warfare Agents · Sponsor: Assistance Publique - Hôpitaux de Paris
This multicenter prospective registry aims to establish a biobank of residual biological samples and associated clinical data from hospitalized patients. The registry will collect a wide range of specimens (serum, plasma, respiratory samples, urine, cerebrospinal fluid, biopsies) obtained during routine care, without any additional procedures. Data are pseudonymized and stored securely for up to 20 years. The biobank will be used to develop and evaluate rapid diagnostic tests (RDTs) for emerging infectious diseases and CBRN threats to improve epidemic preparedness and patient management.
This description comes directly from the study's public registry record.
Thierry NAAS,, PhD · 1 45 21 29 86 · thierry.naas@aphp.fr
Saoussen OUESLATI, PhD · 1 45 21 29 86 · saoussen.oueslati@aphp.fr
Always discuss trial participation with your own doctor first.
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Bicêtre | Le Kremlin-Bicêtre, France | Recruiting |
| CHU Paul Brousse | Villejuif, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07411729